The lung fibroblast derived IGF-I signature was also able to arrange breast carcinoma patients from the NKI dataset into two groups with significantly different times for metastasis free survival and overall survival (P = 7.9e-9 and P = 9.8e-6, respectively, data not shown). The gene discussed is IGF1; the disease is breast carcinoma.